Suzhou Abogen

Covid-19 development round-up: February 25, 2022

The state of the fight: 

Sanofi and GSK’s vaccine candidate demonstrated 58% efficacy against symptomatic Covid-19 in Phase 3.
  Hetero Pharma’s generic version of Merck’s molnupiravir reduced the risk of hospitalization by over 65%.
  Britain and Japan pledged a combined $514 million to CEPI’s pandemic preparedness plan.   AUTHORIZED VACCINES

 
The U.S. FDA lifted its clinical hold on Bharat Biotech’s Covaxin, clearing the way for the inactivated vaccine to…

Mentions:
Covid-19, vaccines, drugs, Bharat Biotech, FDA, Ocugen, Pfizer, BioNTech, CDC, Medicago, GSK, Moderna, Gamaleya Institute, CNBG, Sinopharm, EMA, CanSino, Anhui Zhifei Longcom, Sanofi, Thermo Fisher, Valneva, CEPI, AstraZeneca, Sinovac, Africa CDC, COVAX, WHO, J&J, Vir, Merck, Gilead, Shionogi, Suzhou Abogen, Walvax
Read more
Covid-19 development round-up: December 23, 2020

The state of the hunt:

The Pfizer/BioNTech vaccine received several new authorizations, including from the European Union.
  Canada joined the U.S. in authorizing Moderna’s jab. .
  Argentina and Belarus became the first countries outside Russia to OK Sputnik V.

 

Vaccines


Approved or authorized vaccines
 
Pfizer and BioNTech will market their BNT162b2 vaccine in the European Union under the brand name Comirnaty after receiving…

Mentions:
Covid-19, vaccines, drugs, diagnostics, Pfizer, BioNTech, EU, Moderna, EC, Gamaleya Institute, RDIF, R-Pharm, SII, AstraZeneca, CanSino, Butantan, Sinovac, J&J, IMCAS, Anhui Zhifei Longcom, CureVac, Ocugen, BBIL, Dynavax, University of Saskatchewan, Enesi, ICL, Academy of Military Science, Suzhou Abogen, Walvax, Bio Farma, Arcturus, UNICEF, Walgreens, CVS, CDC, ACIP, halal, Lilly, Regeneron, Dr. Reddy’s, Fujifilm, AIM ImmunoTech, NIH, ACTIV-4, Novan, Catalent, Merck, Abivax, Boehringer Ingelheim, Cologne University Hospital, University of Marburg, DZIF, Innovation Pharmaceuticals, FDA, Inotrem, ImmuneMed, 9 Meters, EBRIS, RADx, Beckman Coulter, NHS, Roche, Africa CDC, AFTCOR, MIS-C, Yale
Read more
Covid-19 development round-up: June 26, 2020

The state of the hunt:

China sent another inactivated candidate to Phase 2—its fourth vaccine of that type to move beyond Phase 1 trials.
  CEPI has identified manufacturing capacity for 4 billion vaccine doses.
  The WHO-led Access to COVID-19 Tools (ACT) Accelerator is seeking almost $28 billion in additional funds.

 

Vaccines

Clinical trials:

Another Chinese candidate in Phase 2: An inactivated vaccine from the Chinese Academy of Medical…

Mentions:
Covid-19, vaccines, drugs, diagnostics, CEPI, WHO, CAMSIMB, CNBG, Walvax, Suzhou Abogen, Genexine, AstraZeneca, Anhui Zhifei Longcom, University of Queensland, Sanofi, GSK, Soligenix, Stevanato Group, Symbiosis Pharmaceutical Services, Daiichi Sankyo, Catalent, Inovio, Chulalongkorn University, ImmunoPrecise, LiteVax, CSU, BARDA, Gavi, COVAX, MSF, Moderna, Vaxart, MMR, EMA, Gilead, Cipla, Hetero, DCGI, FDA, Merck KGaA, Ridgeback Biotherapeutics, Merck, Leidos, Orgenesi, BioSig, ViralClear, Abivax, Oxford University, Glenmark, Relief Therapeutic, Relief Therapeutics, NeuroRx, Novartis, NIH, UNITAID, Schrödinger, Takeda, WuXi AppTec, MBio, Empatica, EU, Global Citizen, Corning, ORNL
Read more
Covid-19 development round-up: May 15, 2020


The state of the hunt: 

Novavax became the biggest recipient of CEPI funds for Covid-19 this week, with a new $384 million award for its recombinant protein vaccine candidate. CureVac’s mRNA vaccine candidate induced high levels of virus-neutralizing titers at a low dose in preclinical studies. Gilead announced voluntary royalty-free licenses for remdesivir with five generic drug manufacturers, and more may be in the works.
 

 

Vaccines

Our Covid-19…

Mentions:
Covid-19, vaccines, Novavax, CEPI, CureVac, Gilead, NRCC, CanSino, Bavarian Nordic, Adaptvac, Moderna, Pfizer, Walvax, Suzhou Abogen, ICMR, BBIL, IITK, Sanofi, Univercells, Exyte, WHO, NIAID, Abivax, Sorrento, Mesoblast, mAbs, Kiniksa, Humanigen, UK, Daewoong, Institut Pasteur Korea, Mayo Clinic, FDA, Quidel, Abbott, Mologic, BioSure, Institut Pasteur de Dakar, Thermo Fisher, Wuxi Diagnostic, Zydus Cadila, UNAIDS, Oxfam, MSF, Gavi, FIND, Wellcome, BARDA, HHS
Read more
Subscribe to Suzhou Abogen